News
APP Pharmaceuticals issues nationwide voluntary recall of Irinotecan Hydrochloride Injection
APP Pharmaceuticals, Inc., announced that it has issued a voluntary recall of five lots of Irinotecan Hydrochloride Injection, which is used for recurrent or...
Press Releases
Ken Jones, COO Europe, Astellas joins GSK, Shire, Takeda and Bausch & Lomb on value based selling panel session
With one week to go SFE Europe shows no sign of slowing down. With over 550 confirmed attendees and an a 80% ratio from...
Research Insight
Cytheris announces results of phase IIa study indicating that recombinant interleukin-7 (CYT107)
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced results of a multi-center...
Articles
Pharma goes mobile: Making the most of the app opportunity
As smartphones and tablets take over, pharma needs a strategic understanding of how mobile solutions improve customer outreach and drive competitive advantage. Andrew Tolve...
Press Releases
Roche announces positive pivotal Phase II results for Hedgehog Pathway Inhibitor in advanced basal cell carcinoma
Roche announced that a pivotal Phase II clinical study of its investigational Hedgehog Pathway Inhibitor, vismodegib (RG3616/GDC-0449), showed positive results in people with advanced...
Press Releases
Novartis completes acquisition of majority stake in Zhejiang Tianyuan
Novartis announced that it completed the transaction to acquire an 85 percent stake in the Chinese vaccines company Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. This...
Press Releases
Phase III Study of Investigational Compound Ipilimumab Achieves Primary Endpoint of Improvement in Overall Survival
Bristol-Myers Squibb Company announced that a clinical trial -- known as study 024 -- of its investigational compound ipilimumab has met the primary endpoint...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read